Jacob Nejtel Kaluski
Direktor/Vorstandsmitglied bei Glactone Pharma AB
Profil
Jacob Nejtel Kaluski founded TKT Europe-5S AB in 2000, where he worked as Director from 2000 to 2004.
Mr. Kaluski also currently works at Glactone Pharma AB, as Director from 2014, Belina AB, as Director from 2018, and Aqilion AB, as Partner from 2010.
Mr. Kaluski also formerly worked at Alligator Bioscience AB, as Director from 2007 to 2010, Jederstrom Pharmaceuticals AB, as Director from 2006 to 2009, DuoCort AB, as Director from 2009 to 2012, Bioimics AB, as Director from 2010 to 2013, Pulsetten AB, as Director from 2012 to 2016, Centogene AG, as Member-Supervisory Board, and Centogene NV, as Member-Supervisory Board from 2015 to 2020.
Mr. Kaluski received his graduate degree from the University of Uppsala.
Aktive Positionen von Jacob Nejtel Kaluski
| Unternehmen | Position | Beginn |
|---|---|---|
Glactone Pharma AB
 Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Direktor/Vorstandsmitglied | 01.01.2014 |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Private Equity Investor | 11.06.2010 |
| Belina AB | Direktor/Vorstandsmitglied | 01.01.2018 |
Ehemalige bekannte Positionen von Jacob Nejtel Kaluski
| Unternehmen | Position | Ende |
|---|---|---|
| CENTOGENE N.V. | Direktor/Vorstandsmitglied | 16.03.2020 |
| Pulsetten AB | Direktor/Vorstandsmitglied | 01.01.2016 |
| Bioimics AB | Direktor/Vorstandsmitglied | 01.01.2013 |
DuoCort AB
 DuoCort AB Pharmaceuticals: MajorHealth Technology DuoCort AB manufactures pharmaceutical products. The company is based in Helsingborg, Sweden. The Swedish company was founded by Thomas Hedner. | Direktor/Vorstandsmitglied | 01.01.2012 |
| ALLIGATOR BIOSCIENCE AB | Direktor/Vorstandsmitglied | 01.01.2010 |
Ausbildung von Jacob Nejtel Kaluski
| University of Uppsala | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CENTOGENE N.V. | Commercial Services |
| ALLIGATOR BIOSCIENCE AB | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Jederstrom Pharmaceuticals AB
 Jederstrom Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Jederstrom Pharmaceuticals is a life sciences company that is developing new formulations for oral delivery of therapeutic proteins. These new formulations offer new and improved therapeutic possibilities, cost advantages and the convenience factor of oral administration. The vision of Jederstrom Pharmaceuticals is to make oral administration the method of choice for a number of key therapeutic proteins. Jederstrom Pharmaceuticals initial focus is to develop an insulin formulation for oral administration. Formulations of other well-known therapeutic proteins will then be developed. Jederstrom Pharmaceuticals' business model shall be out licensing. Jederstrom Pharmaceuticals was founded in 2001 by Gustaf Jederström, inventor of the formulation technology. Gustaf Jederström has more than 30 years experience of R&D in the pharmaceutical industry, where he has been instrumental in bringing numerous new pharmaceutical products to market. | Health Technology |
TKT Europe-5S AB
 TKT Europe-5S AB Medical DistributorsDistribution Services Part of Takeda Pharmaceutical Co., Ltd., TKT Europe-5S AB is a Swedish company that markets, sells, and distributes pharmaceutical products. The company is based in Danderyd, Sweden. The company was founded by Jacob Nejtel Kaluski. TKT Europe-5S was acquired by Transkaryotic Therapies, Inc. on October 22, 2004 for $61 million. | Distribution Services |
Centogene AG
 Centogene AG Medical/Nursing ServicesHealth Services Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany. | Health Services |
Glactone Pharma AB
Glactone Pharma AB Pharmaceuticals: MajorHealth Technology Glactone Pharma AB engages in the development of pipeline of novel signal transducer and activator of transcription 3 inhibitors. Its pipeline is used for immuno-oncology and for the treatment of drug resistant cancers, including castration resistant prostate cancer. The company was founded by Anders Sigvard Bjartell, Rebecka Hellsten, Martin Johansson, Eduardo Munoz, and Olov Arvid Sterner in 2012 and is headquartered in Helsingborg, Sweden. | Health Technology |
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Finance |
| Belina AB | |
| Pulsetten AB | |
| Bioimics AB | |
DuoCort AB
DuoCort AB Pharmaceuticals: MajorHealth Technology DuoCort AB manufactures pharmaceutical products. The company is based in Helsingborg, Sweden. The Swedish company was founded by Thomas Hedner. | Health Technology |
